(Date:11/24/2009)...--IES(Nasdaq: IESC ),aleadingnationalproviderofele...mmercial,industrialandresidentialmarkets,announced...contractfromManhattanTorconJVtoinstalltheelectrica...tfacilityattheU.S.ArmyMedicalResearchInstituteofIn...,Md. ,, ThenewUSAMRIIDreplacementfacilitywillad...
(Date:11/24/2009)...ire-FirstCall/--deCODE,genetics,Inc.(Nasdaq: DCGN ...aqStockMarketthattradinginthecompany,scommonstockw...llbefiledwiththe,SecuritiesandExchangeCommission,w...daq,unlessthecompanyfilesanappealtotheNasdaq,Listi...al,which,willstaythesuspensionanddelistingthrought...
(Date:11/24/2009)...rstCall/--NeurogesX,Inc.(Nasdaq: NGSX ),abiopharma...ngnovelpainmanagementtherapies,announcedtodaythatA...scheduledtopresentatthe21stAnnualPiperJaffrayHealt...rkPalaceHotelinNewYork,NewYork. ,, Mr.DiTonnoan...labletorespondtoquestionsduringthepresentationsand...
(Date:11/24/2009).../PRNewswire-FirstCall/-HamiltonThorneLtd.(TSX-V:HT...vancedlasersystemsandinstrumentsforthestemcellrese...onalandfinancialresultsforthethirdquarterendedSept...46millioncomparedwith$1.43millioninQ32008,-Grosspr...3,2008,-Netlossreducedto$148,000comparedto$283,000...
Breaking Biology Technology:Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7...Berkeley -- Fossils discovered in the oft-painted ...time that dinosaurs and their non-dinosaur ancesto...s, disproving the notion that dinosaurs rapidly re...The fossils were excavated from the Hayden Quarry ...
NEW YORK (July 17, 2007) -- Challenging brain tissue with a small noxious stimulus beforehand gives it a resilience that can lessen damage to blood vessels during a stroke, report researchers at Weill
...The QCTN Biotech Rising Star Award is intended to ...ed as...having the potential to make significant c...dustry or research...sector Queenslands Rising St... said it is important to acknowledge the achieveme...
This release is also available in Spanish. ... This international collaboration has been the largest ever to have taken place in a large scale study on genetic differences between patients infected by
Rise of dinosaurs in Late Triassic more gradual than once thought 2Rise of dinosaurs in Late Triassic more gradual than once thought 3Rise of dinosaurs in Late Triassic more gradual than once thought 4'Preconditioning' helps protect brain's blood vessels from stroke 2'Preconditioning' helps protect brain's blood vessels from stroke 3Awards celebrating women and biotech brilliance 2Identified main genetic variants involved in response to HIV 2... or a bowl of...bran cereal, you're likely to get ...ers now have a better idea why.......A UC Davis st...of Clinical Nutrition, indicates that increased fi...s in women and increases...levels of a certain hor...
...make Kansas a better place for llamas and alpacas....sor of anatomy and physiology said there are rough... States and it is difficult to find sufficient dru...s are concerned, they aren't even a blip on the ma...
Dec. 5 and 6, Thursday and Friday -- Experts from France...and the U.S. will discuss diseases such as smallpox,...influenza, Ebola virus and plague, and how these threats can...be countered, at a two
...XiGENE, Inc. (Nasdaq: OXGN, SSE: OXGN), in a step ...esearch of its lead vascular...targeting compound,......the signing of a funded research agreement with...ndation is a nationwide charitable...organization ...
Increased fiber curbs appetite in women 2OXiGENE, foundation fighting blindness sign research agreement for phase I/II clinical trial 2OXiGENE, foundation fighting blindness sign research agreement for phase I/II clinical trial 3